Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
about
Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum modelThe glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosaDynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.Beta-lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein.Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections.Emergence and spread of antibiotic resistance following exposure to antibiotics.Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.The problems of antibiotic resistance in cystic fibrosis and solutions.Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
P2860
Q28359832-900463A9-2F3A-4CC7-9614-BB61AB7C2150Q28492495-C46DEAF0-3917-440B-92A4-B6346837C371Q31029779-091ED486-C189-4066-BC65-69AD679566B6Q33422951-AC498E21-4568-41CB-825C-D6062C93AA55Q33876563-0EB06503-44DE-45F7-A656-536639808DDDQ34082906-B8AB548C-CF01-430A-8F6F-FCD6FF4FDC24Q34117477-4ADC4DC3-9932-4E1A-8DAD-7ACA00E9A034Q34932869-61D28D14-99B0-4745-8A69-02D9143773A3Q35350270-2D05133F-36C4-48E7-929D-1C684B288A93Q37896674-C2A98B68-06D5-4E4B-8604-F38D6FD31F79Q38273318-D513D6BC-B641-48A4-8772-DD74311CD57FQ38300820-2E350F63-44B9-4986-99EF-94DF74B29D11Q41937031-2DFA3C92-8ECE-4C34-BB03-102A3D193D39Q42717931-1775C7AA-A21B-440A-9484-7986991B30A7Q42909082-7A07A1EF-CEDB-4A23-876C-9969CBDF7BA6Q43153453-A0BCE756-FE5D-4337-AAE2-5D3E0BAFBDED
P2860
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Influence of high mutation rat ...... mbined antipseudomonal agents.
@ast
Influence of high mutation rat ...... mbined antipseudomonal agents.
@en
type
label
Influence of high mutation rat ...... mbined antipseudomonal agents.
@ast
Influence of high mutation rat ...... mbined antipseudomonal agents.
@en
prefLabel
Influence of high mutation rat ...... mbined antipseudomonal agents.
@ast
Influence of high mutation rat ...... mbined antipseudomonal agents.
@en
P2093
P2860
P356
P1476
Influence of high mutation rat ...... ombined antipseudomonal agents
@en
P2093
P2860
P304
P356
10.1128/AAC.00174-07
P407
P577
2007-04-30T00:00:00Z